89bio to participate in the 6th annual evercore isi healthconx conference

San francisco, nov. 21, 2023 (globe newswire) -- 89bio, inc. (nasdaq: etnb), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the company's management will participate in a fireside chat at the 6th annual evercore healthconx conference on tuesday, november 28, 2023 at 8:45 am et and participate in one-on-one investor meetings.
ETNB Ratings Summary
ETNB Quant Ranking